Slow-k and Haloperidol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Slow-k (potassium chloride) and Haloperidol (haloperidol). Common drug interactions include lung infection among females and lipase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Slow-k and Haloperidol. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Slow-k?

Slow-k has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 3,683 Slow-k users. Check the latest studies of Slow-k.

What is Haloperidol?

Haloperidol has active ingredients of haloperidol. It is often used in schizophrenia. eHealthMe is studying from 16,637 Haloperidol users. Check the latest studies of Haloperidol.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 15, 2026

19 people who take Slow-k and Haloperidol together, and have interactions are studied.

Slow-k and Haloperidol drug interactions.

What are the common drug interactions of Slow-K and Haloperidol, by gender? *:

female:

  1. Lung infection
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Hyperglycaemia (high blood sugar)
  6. Infection
  7. Neutropenia (an abnormally low number of neutrophils)
  8. Pulmonary cavitation (cavity in the lung)
  9. Melaena (the passage of black, tarry stools)
  10. Dyspepsia (indigestion)

male:

  1. Lipase increased
  2. Epstein-barr virus associated lymphoproliferative disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus)
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Insomnia (sleeplessness)
  5. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  6. Dehydration (dryness resulting from the removal of water)
  7. Diarrhoea
  8. Abnormal behaviour
  9. Aggression
  10. Libido disorder (a sexual dysfunction relating to loss of sexual desire)

What are the common drug interactions of Slow-K and Haloperidol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Lipase increased
  2. Epstein-barr virus associated lymphoproliferative disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus)
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Insomnia (sleeplessness)

50-59:

  1. Lung infection
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Infection
  6. Neutropenia (an abnormally low number of neutrophils)
  7. Pulmonary cavitation (cavity in the lung)
  8. Respiratory tract infection bacterial
  9. Respiratory tract infection fungal

60+:

  1. Hyperglycaemia (high blood sugar)
  2. Melaena (the passage of black, tarry stools)
  3. Oesophagitis (inflammation of oesophagus)
  4. Weakness
  5. Abnormal behaviour
  6. Aggression
  7. Bacterial infection
  8. Blood pressure decreased
  9. Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
  10. Cardiomegaly (increased size of heart than normal)

What are the existing conditions these people have? *

  1. Urinary Tract Infection: 7 people, 36.84%
  2. Night Sweats (sweating in night): 7 people, 36.84%
  3. Anaemia (lack of blood): 7 people, 36.84%
  4. Blood Glucose Increased: 7 people, 36.84%
  5. Depression: 7 people, 36.84%
  6. Fluid Retention (an abnormal accumulation of fluid in the blood): 7 people, 36.84%
  7. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 7 people, 36.84%
  8. Hypotension (abnormally low blood pressure): 7 people, 36.84%
  9. Infection: 7 people, 36.84%
  10. Menopausal Symptoms: 7 people, 36.84%

* Approximation only. Some reports may have incomplete information.

Do you take Slow-k and Haloperidol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Slow-k and Haloperidol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Slow-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Haloperidol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Slow-k and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Haloperidol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride and haloperidol (the active ingredients of Slow-k and Haloperidol, respectively), and Slow-k and Haloperidol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: